Myriad Genetics, Inc. (MYGN) Stock Overview
NASDAQ · Healthcare · Diagnostics & Research
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Myriad Genetics, Inc.
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers;…
Source: Yahoo Finance
Sector & Industry
Myriad Genetics, Inc. operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NASDAQ exchange.
Myriad Genetics, Inc. at a Glance
| Company | Myriad Genetics, Inc. |
| Ticker | MYGN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $3.19 |
| Market cap | $305.12M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.18 |
| 52-week high | $8.59 |
| 52-week low | $2.74 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.64 |
| Return on equity (ROE) | -23.51% |
| Debt-to-equity | 32.84% |
| Average volume | 1.82M |
| Shares outstanding | 95.65M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 2,700 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Myriad Genetics, Inc.'s current P/E ratio?
- Myriad Genetics, Inc. (MYGN) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Myriad Genetics, Inc.'s market capitalisation?
- Myriad Genetics, Inc.'s market cap is $305.12M based on our latest snapshot. See how it ranks by market cap →
- What is MYGN's 52-week range?
- Over the past 52 weeks, MYGN has traded between $2.74 and $8.59. What does the 52-week range mean? →
- How volatile is Myriad Genetics, Inc. compared to the market?
- Myriad Genetics, Inc. has a beta of 1.64, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Myriad Genetics, Inc. pay a dividend?
- Myriad Genetics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is MYGN listed on?
- MYGN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Myriad Genetics, Inc. in?
- Myriad Genetics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →